Is Vesilut FDA approved?
No. This profile records Vesilut as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
Vesilut
THE BLADDER COMFORTER
A-12 Bladder Bioregulator Peptide, Vesilute
Vesilut is a bioregulator peptide extracted from bladder tissue that helps heal and restore bladder function. It reduces inflammation, repairs the bladder lining, and improves neuromuscular control of the bladder. Particularly helpful for chronic bladder irritation, interstitial cystitis, and age-related urinary issues.
Vesilut
Vesilut
Vesilut
Vesilut Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Vesilut
What dose does The Peptide App Clinical Team recommend for Vesilut?
Dose: 20 mg orally or subcutaneously each morning.
MORE CONTEXT ›
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Vesilut guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Barrier Restoration
Promotes tight junction proteins (E-cadherin, claudins, uroplakins) for bladder lining
Anti-Inflammatory
Inhibits COX-2 and NF-κB pathways to reduce bladder inflammation
Neuromuscular Support
Modulates muscarinic and adrenergic receptors for better bladder control
People with interstitial cystitis or chronic cystitis
Those with overactive bladder or urgency issues
Anyone with age-related bladder weakness
People with neurogenic bladder conditions
Those with pelvic discomfort or urinary frequency
Vesilut Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES